UroToday5d
Clarity and Nucleus RadioPharma Sign Master Services Agreement and Cu-67 SAR-bisPSMA Clinical Supply Agreement
The Master Services Agreement (MSA) and Clinical Supply Agreement with Nucleus RadioPharma complement the existing agreement with NorthStar Medical Radioisotopes, LLC (NorthStar) for 67Cu-SAR-bisPSMA ...
UroToday10d
Leaders in Radiopharmaceuticals: Disruptive Innovations and Personal Perspectives
Radiopharmaceuticals and Combination Approaches in Advancing the Prostate Cancer Treatment Landscape - Philip Kantoff ...
UroToday4d
Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer.
Intravesical therapy is a critical component in the management of non-muscle-invasive bladder cancer (NMIBC), as it reduces rates of disease recurrence and progression. However, the presence of ...
UroToday4d
A review of the performance of urinary cytology with a focus on atypia, upper tract and updates on novel ancillary testing.
The Paris System for Reporting Urine Cytology (TPS) is remarkable for its high predictive value in the detection of high-grade urothelial carcinoma, especially of the bladder. However, universal ...
UroToday4d
Patients' anxieties and fears: a comparison between transrectal prostate biopsy and prostate MRI.
Prostate biopsies are an invasive procedure that can lead to anxieties and fear before the examination. Prostate magnetic resonance imaging (MRI) is seen as a non-invasive test although it is known ...
UroToday5d
Role of lingual mucosa as a graft material in the surgical treatment of Peyronie's disease.
Peyronie's disease (PD) is a localized fibrosis of tunica albuginea, which causes the anatomical and functional changes to the penis. Corporoplasty with grafting is indicated in severe (>60°) and ...
UroToday5d
Efficacy and Predictive Factors Analysis of Androgen Deprivation Plus Novel Hormone Therapy as Neoadjuvant Treatment for High-Risk Prostate Cancer.
This investigation explored the clinical features, pathological outcomes, and biochemical recurrence (BCR) duration among high-risk prostate cancer (HRPC) patients who have undergone neoadjuvant ...
UroToday5d
Advanced Imaging for Localized Prostate Cancer.
Prostate cancer is a prevalent malignancy often presenting without early symptoms. Advanced imaging technologies have revolutionized its diagnosis and management. This review discusses the principles, ...
UroToday5d
Survival improvement over time in renal cell carcinoma treated with nephrectomy: A longitudinal propensity score-matched study.
Surgical treatment for renal cell carcinoma (RCC) has drastically evolved for the past 30 years. However, survival outcomes of RCC according to times have not been fully elucidated, especially in the ...
UroToday5d
A novel approach to engineering three-dimensional bladder tumor models for drug testing.
Bladder cancer (BCa) poses a significant health challenge, particularly affecting men with higher incidence and mortality rates. Addressing the need for improved predictive models in BCa treatment, ...
UroToday5d
Commercial prices and their influence on urology practices: Prostate cancer care among men with Medicare.
For men with prostate cancer, there is substantial variation in the use of conservative management, such as active surveillance. Commercial prices, which vary across urology practices, may afford ...